Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 4:01 p.m.

    📋 Imago BioSciences, Inc. (IMGO) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 16:28:43

    Event Type: Financial Results

    Event Details:

    Imago Biosciences Inc (the company became a subdivision of the company Merck (NYSE: MRK)) (IMGO) Reports Q2 2022 Financial Results Imago Biosciences Inc (the company became a subdivision of the company Merck (NYSE: MRK)) (IMGO) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 8259

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 3.16K 3.89K $-735.00 -18.88%
    Current Assets Property Equipment Net 4.00 2.00 $2.00 +100.00%
    Current Liabilities Accounts Payable 3.33K 3.46K $-134.00 -3.87%
    Operating Expenses Loss From Operations 16.51K 7.15K $9.37K +131.02%
    Other Income Expense Net Interest Income 64.00 87.00 $-23.00 -26.44%
    Other Income Expense Net Total Other Income Expense 55.00 48.00 $7.00 +14.58%
    Other Income Expense Net Net Loss 16.39K 7.11K $9.29K +130.61%
    Other Income Expense Net Net Loss Per Share 0.49 6.90 $-6.41 -92.90%
    Other Income Expense Net Weighted Average Shares 33.65M 1.03M $32.62M +3166.53%
    Prepaid Expenses and Other Current Assets 3.16K 3.89K $-735.00 -18.88%
    Property and Equipment, Net 4.00 2.00 $2.00 +100.00%
    Accounts Payable 3.33K 3.46K $-134.00 -3.87%
    Loss from Operations 16.51K 7.15K $9.37K +131.02%
    Interest Income 64.00 87.00 $-23.00 -26.44%
    Other Income, Net 119.00 39.00 $80.00 +205.13%
    Net Loss 16.39K 7.11K $9.29K +130.61%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Imago Biosciences Inc (the company became a subdivision of the company Merck (NYSE: MRK))
    • CIK: 0001623715
    • Ticker Symbol: IMGO
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories